Cargando…
Porphyria and kidney diseases
The kidneys, after the bone marrow and liver, are third in terms of the amounts of haem synthesized daily. Haem is incorporated into haemoproteins that are critical to renal physiology. In turn, disturbances in haem metabolism interfere with renal physiology and are tightly interrelated with kidney...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888040/ https://www.ncbi.nlm.nih.gov/pubmed/29644058 http://dx.doi.org/10.1093/ckj/sfx146 |
_version_ | 1783312442436091904 |
---|---|
author | Pallet, Nicolas Karras, Alexandre Thervet, Eric Gouya, Laurent Karim, Zoubida Puy, Hervé |
author_facet | Pallet, Nicolas Karras, Alexandre Thervet, Eric Gouya, Laurent Karim, Zoubida Puy, Hervé |
author_sort | Pallet, Nicolas |
collection | PubMed |
description | The kidneys, after the bone marrow and liver, are third in terms of the amounts of haem synthesized daily. Haem is incorporated into haemoproteins that are critical to renal physiology. In turn, disturbances in haem metabolism interfere with renal physiology and are tightly interrelated with kidney diseases. Acute intermittent porphyria causes kidney injury, whereas medical situations associated with end-stage renal disease, such as porphyrin accumulation, iron overload and hepatitis C, participate in the inhibition of uroporphyrinogen decarboxylase and predispose the individual to porphyria cutanea tarda. Even if some of these interactions have been known for a long time, the clinical situations associated with these interrelations have strikingly evolved over time with the advent of new therapeutic strategies for dialysis therapy and a better understanding of the pathophysiological mechanisms of porphyria-associated kidney disease. Physicians should be aware of these interactions. The aim of this review is to summarize the complex interactions between kidney physiology and pathology in the settings of porphyria and to emphasize their often-underestimated importance. |
format | Online Article Text |
id | pubmed-5888040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58880402018-04-11 Porphyria and kidney diseases Pallet, Nicolas Karras, Alexandre Thervet, Eric Gouya, Laurent Karim, Zoubida Puy, Hervé Clin Kidney J Genetic Diseases The kidneys, after the bone marrow and liver, are third in terms of the amounts of haem synthesized daily. Haem is incorporated into haemoproteins that are critical to renal physiology. In turn, disturbances in haem metabolism interfere with renal physiology and are tightly interrelated with kidney diseases. Acute intermittent porphyria causes kidney injury, whereas medical situations associated with end-stage renal disease, such as porphyrin accumulation, iron overload and hepatitis C, participate in the inhibition of uroporphyrinogen decarboxylase and predispose the individual to porphyria cutanea tarda. Even if some of these interactions have been known for a long time, the clinical situations associated with these interrelations have strikingly evolved over time with the advent of new therapeutic strategies for dialysis therapy and a better understanding of the pathophysiological mechanisms of porphyria-associated kidney disease. Physicians should be aware of these interactions. The aim of this review is to summarize the complex interactions between kidney physiology and pathology in the settings of porphyria and to emphasize their often-underestimated importance. Oxford University Press 2018-04 2018-01-10 /pmc/articles/PMC5888040/ /pubmed/29644058 http://dx.doi.org/10.1093/ckj/sfx146 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Genetic Diseases Pallet, Nicolas Karras, Alexandre Thervet, Eric Gouya, Laurent Karim, Zoubida Puy, Hervé Porphyria and kidney diseases |
title | Porphyria and kidney diseases |
title_full | Porphyria and kidney diseases |
title_fullStr | Porphyria and kidney diseases |
title_full_unstemmed | Porphyria and kidney diseases |
title_short | Porphyria and kidney diseases |
title_sort | porphyria and kidney diseases |
topic | Genetic Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888040/ https://www.ncbi.nlm.nih.gov/pubmed/29644058 http://dx.doi.org/10.1093/ckj/sfx146 |
work_keys_str_mv | AT palletnicolas porphyriaandkidneydiseases AT karrasalexandre porphyriaandkidneydiseases AT therveteric porphyriaandkidneydiseases AT gouyalaurent porphyriaandkidneydiseases AT karimzoubida porphyriaandkidneydiseases AT puyherve porphyriaandkidneydiseases |